Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
44.20
-0.60 (-1.33%)
Jan 31, 2025, 10:49 AM EST - Market open
Janux Therapeutics Market Cap
Janux Therapeutics has a market cap or net worth of $2.55 billion as of January 31, 2025. Its market cap has increased by 469.76% in one year.
Market Cap
2.55B
Enterprise Value
1.95B
1-Year Change
469.76%
Ranking
Category
Stock Price
$44.20
Market Cap Chart
Since the IPO on June 11, 2021, Janux Therapeutics's market cap has increased from $613.73M to $2.55B, an increase of 315.17%. That is a compound annual growth rate of 47.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2025 | 2.58B | -16.34% |
| Dec 31, 2024 | 3.09B | 523.34% |
| Dec 29, 2023 | 495.20M | -9.51% |
| Dec 30, 2022 | 547.22M | -33.35% |
| Dec 31, 2021 | 821.00M | 33.77% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 728.89B |
| UnitedHealth Group | 498.11B |
| Novo Nordisk | 378.98B |
| Johnson & Johnson | 363.53B |
| AbbVie | 309.38B |
| Merck & Co. | 246.31B |
| Thermo Fisher Scientific | 222.87B |
| Abbott Laboratories | 221.13B |